Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

What Does Xerox Bid Mean for HP Stock Approaching Earnings?

Xerox is trying to buy out Hewlett Packard. Meanwhile, HP has earnings coming up in a few days. What's it all mean for HP stock?

Sell Any Bounce in Hexo Stock After Massive Earnings Flop

Like many of its marijuana peers, Hexo stock gave investors a terrible earnings report this quarter. And things aren't getting better anytime soon.

It’s Time to Give Up on Aurora Cannabis Stock

Sure, Aurora's earnings report was disappointing. The devil is in the details though - share dilution threatens to hit ACB stock even harder going forward.

Qualcomm Stock Is Still a Good Stock If You Can Wait Until 2020

Qualcomm's recent earnings report was fine enough. But traders are waiting to see what happens with 5G deployment in 2020.

Grab JD Stock While the Market Snoozes Despite Its Blowout Earnings

JD.com's skeptics are running out of arguments after another dazzling earnings report. JD stock is heading higher over the next year.

7 Penny Stocks to Consider Buying Now

Are you interested in penny stocks and looking for some safe picks that could have surprising upside. Here are seven names you need to watch.

AMD Stock Benefits from a Clash Between Traders and Investors

AMD stock traders have won the latest battle, pushing the company's stock to multi-year highs. But the longer-term investment picture isn't so bright.

As Its Cloud Pivot Gets Underway, Don’t Count out IBM Stock Just Yet

Analysts are saying that IBM stock is now a 2020 story after generally downbeat Q3 earnings. Here's what you need to know.

Should Investors Buy Pfizer Stock Before Next Year’s Huge Shake Up?

There's a strong case for investing in Pfizer stock. With a great deal of uncertainty in the near-term, however, some patience with PFE stock may be required.

7 Tech Stocks to Buy for the Rest of 2019

Historically, the end of the year is the most profitable time for stocks. With that in the mind, here are seven tech names to pick up during holiday shopping.